Layoff
Jul 2023Biofourmis confirmed layoffs of about 120 employees globally, including 48 in the U.S.
SourceCompany research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Biofourmis is a privately held digital health and care-delivery company that uses an AI-driven platform to support hospital-at-home, remote patient monitoring, and virtual care across the care continuum. The company merged with CopilotIQ in 2024; its life-sciences digital-trial business was later acquired by ActiGraph in January 2025.
Primary product
Biofourmis Care, an AI-driven in-home care and remote patient monitoring platform (with Biovitals as the underlying analytics platform)
Founded
2015
Headquarters
Needham, Massachusetts, United States
Team size
51-200
Industry
Hospitals and Health Care
Sub-industry
Digital health / virtual care / remote patient monitoring
Offices
Needham, Massachusetts, United States
Boston, Massachusetts, United States
Singapore
Bengaluru, India
Funding
Stage
Late Stage Venture
Total raised
$463.6M
Latest round
Series D Extension · Jul 2022
Latest amount
$20M
Oct 2024 · CopilotIQ
Jul 2022 · Intel Capital
People & investors
Leadership
Chief Executive Officer
Chief Revenue Officer
Chief Medical Officer
Work & culture
Mission-driven and fast-growing digital health culture centered on personalized care, complex chronic conditions, and outcome improvement. Public career pages and third-party profiles describe the team as globally distributed, committed, and focused on clinical and operational impact.
Compensation
Public salary signals are limited, but LinkedIn/job-site data suggests mid-market pay with a compensation rating around 3.6/5 and example postings/reported roles around USD 59.8k/year for Technical Support Analyst, USD 133.4k/year for Data Science Manager, and roughly SGD 42k/month for a Systems Engineer role.
Benefits
Company equity
Performance bonuses
Family medical leave
Generous parental leave
Dental insurance
Product & market
Pricing
Enterprise B2B contracts for healthcare organizations; public pricing is not disclosed and the company appears to use value-based / shared-savings style economics for some deployments.
Differentiators
- —AI-driven in-home care across pre-surgery, acute, post-acute, and chronic care
- —Continuous monitoring with 120+ biomarkers in real time
- —Integrated virtual clinical teams and in-home services
- —FDA-cleared AI algorithms
- —Care-at-home platform built for hospitals, health systems, and payers
- —Proven workflow support for remote patient monitoring and hospital-at-home programs
- —Global footprint with licensed operations in 25 U.S. states
Technology
Python
Scale & contact
Estimated revenue
$200M-$300M
Estimated monthly visits
902
Traffic estimate as of May 2026
Signals & risks
Layoff
Oct 2023The company reportedly conducted another layoff round affecting about 45 staff in Singapore and at least 85 globally, and planned to vacate its Singapore office.
SourceLatest news
STAT · Jan 2025
ActiGraph acquired Biofourmis' life sciences business, a deal that re-scoped Biofourmis toward care delivery and away from its digital-trial business.
Biofourmis · Jan 2025
Biofourmis announced a collaboration with AdventHealth to expand remote patient management and hospital-at-home care in Central Florida.
Business Wire · Nov 2024
Biofourmis announced a partnership with Lee Health to support RPM and launch a hospital-at-home program.
Biofourmis · Oct 2024
Biofourmis and CopilotIQ announced a strategic merger to create an AI-driven in-home care platform spanning pre-surgery, acute, post-acute, and chronic care.